China Pharma Holdings (CPHI) EV to EBIT (2010 - 2026)
China Pharma Holdings' (CPHI) quarterly EV to EBIT came in at 18.47 in Q2 2026, down 130.95% on a YoY basis from 59.66 in Q2 2025, and down 33.56% quarter-over-quarter from 13.83 in Q1 2026.
Powered by 
Analysis
China Pharma Holdings (CPHI) EV to EBIT (2010 - 2026) Analysis & Trends
China Pharma Holdings (CPHI) has reported EV to EBIT for 17 consecutive years, with 18.47 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, EV to EBIT fell 130.95% year-over-year to 18.47; the trailing twelve-month figure through Jun 2026 stood at 6.04 (down 327.69% YoY), and the FY2025 full-year result was 1.5, down 100.02% from the prior year.
- EV to EBIT slipped to 18.47 in Q2 2026 per CPHI's latest filing, from 13.83 in the prior quarter.
- Across five years, EV to EBIT topped out at 0.53 in Q4 2023 and bottomed at 18.47 in Q2 2026.
- Historically, EV to EBIT has averaged 7.1 across 5 years, with a median of 5.22 in 2024.
- The sharpest annual moves came in 2022 and 2024: EV to EBIT jumped 90.71% in 2022, then sank 445.6% in 2024.
- Over 5 years, EV to EBIT stood at 2.58 in 2022, then surged by 79.57% to 0.53 in 2023, then sank by 445.6% to 2.87 in 2024, then tumbled by 40.7% to 4.04 in 2025, then plunged by 357.19% to 18.47 in 2026.
- According to Business Quant data, EV to EBIT over the past three periods registered 18.47, 13.83, and 4.04 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn |
| 10 | China Pharma Holdings | 31.39 Mn | 31.08 Mn | 83,566.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -18.47 |
| Mar 31, 2026 | -13.83 |
| Dec 31, 2025 | -4.04 |
| Sep 30, 2025 | -11.55 |
| Jun 30, 2025 | -8.00 |
| Mar 31, 2025 | -10.77 |
| Dec 31, 2024 | -2.87 |
| Sep 30, 2024 | -3.23 |
| Jun 30, 2024 | -2.53 |
| Mar 31, 2024 | -5.09 |
| Dec 31, 2023 | -0.53 |
| Sep 30, 2023 | -0.82 |
| Jun 30, 2023 | -4.34 |
| Mar 31, 2023 | -5.36 |
| Dec 31, 2022 | -2.58 |
| Sep 30, 2022 | -6.47 |
| Jun 30, 2022 | -10.69 |
| Mar 31, 2022 | -16.59 |
| Dec 31, 2021 | -27.73 |
| Sep 30, 2021 | -34.02 |